tiprankstipranks
Yumanity Therapeutics (YMTX)
NASDAQ:YMTX

Yumanity Therapeutics (YMTX) Dividend Date & History

642 Followers
No upcoming dividends
Yumanity Therapeutics has no upcoming dividends

Dividend Amount Per Share​

YMTX Dividend Yield Range

Currently, no data available
Please return soon. This page is being updated.

YMTX Dividend History

Ex-Date
Amount
Frequency
Declaration Date
Record Date
Payment Date
Dec 19, 2022$1.43Not AvailableDec 19, 2022
The table shows Yumanity Therapeutics’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

Does Yumanity Therapeutics pay dividends?
Yes, YMTX has paid a dividend within the past 12 months.
    How much is Yumanity Therapeutics's dividend?
    Yumanity Therapeutics (YMTX) does not pay a dividend
    When is Yumanity Therapeutics ex-dividend date?
    Yumanity Therapeutics's previous ex-dividend date was on Dec 19, 2022. Yumanity Therapeutics shareholders who own YMTX stock before this date received Yumanity Therapeutics's last dividend payment of $1.43 per share on Dec 19, 2022. YMTX's next ex-dividend date has not been announced yet.
      When is Yumanity Therapeutics dividend payment date?
      Yumanity Therapeutics’s next quarterly payment date is on Dec 19, 2022, when Yumanity Therapeutics shareholders who owned YMTX shares before Dec 19, 2022 received a dividend payment of $1.43 per share. Add YMTX to your watchlist to be reminded of YMTX's next dividend payment.
        Does Yumanity Therapeutics have sufficient earnings to cover their dividend?
        Yes, YMTX's past year earnings per share was -$20.85, and their annual dividend per share is $1.43. YMTX's dividend payout ratio is -6.83% ($1.43/-$20.85) which is not sustainable.
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis